Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
about
A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014Optimizing the virological success of tenofovir DF/FTC/rilpivirine in HIV-infected naive and virologically suppressed patients through strict clinical and virological selection.Renal Drug Transporters and Drug Interactions.Switching to a rilpivirine/emtricitabine/tenofovir single-tablet regimen in RNA-suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks.Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial.MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
P2860
Q35149475-3B22898F-6107-487F-96B1-BD717C5549D1Q35628276-3362D955-17C3-41B8-80BF-7B3C185734C1Q38379391-3ABE4DC6-0569-46D1-9371-9B9D826C18B3Q39140289-FF85748A-DFD3-4749-9125-DD9DE56FD042Q40116904-2038F509-9B45-4876-9D36-C3EBE5A7BBA8Q41230514-50C5A6C1-3B08-4AB5-AF01-8EFD00E97708Q48145638-B9977A8C-2214-43B1-BC11-50C374A95016Q54240869-B704F008-DBD4-428D-B3E2-846396A1DFBFQ54942910-4C09FB50-796F-4B79-8D90-5C897525FFAC
P2860
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
@en
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.
@nl
type
label
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
@en
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.
@nl
prefLabel
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
@en
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro.
@nl
P2860
P50
P356
P1476
Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro
@en
P2093
David J Back
P2860
P304
P356
10.1128/AAC.01421-13
P407
P577
2013-09-03T00:00:00Z